Sbir topic 111, phase i, oxygen delivery device innovations
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92021C00030
- Awardee
-
TDA Research, Inc. UEI MK5ANJVWVZK7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · PHS20211 · Posted Jul 9, 2020
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Denver, CO 80033, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $300,000 |
About this award
TDA Research, Inc., a small business specializing in advanced materials science and medical device innovations, was awarded a $300,000 Small Business Innovation Research (SBIR) Phase I contract by the National Heart, Lung, and Blood Institute on September 27, 2021. The contract, designated as a total small business set-aside with a firm fixed-price structure, supports research under SBIR Topic 111 focused on oxygen delivery device innovations. Work is being performed at TDA Research's facility in Wheat Ridge, Colorado, with an ultimate completion date of November 26, 2022. This award emerged from a July 2020 pre-solicitation notice seeking biomedical and public health research proposals across multiple research areas, including cardiovascular and respiratory health technologies.
The contract reflects TDA Research's established track record as a federal contractor with demonstrated expertise in translating innovative concepts into deployable solutions across defense and civilian government agencies. The company has successfully executed numerous SBIR and STTR awards for the Department of Defense, NASA, the Department of Energy, and the National Institutes of Health, with prior accomplishments including portable oxygen generators for casualty care and advanced medical device development. This Phase I award provides the foundation for potential Phase II expansion efforts, enabling the company to advance oxygen delivery technologies that align with the National Heart, Lung, and Blood Institute's mission to develop innovations addressing pulmonary and cardiovascular health challenges.
Quick answers
Who was awarded contract 75N92021C00030?
75N92021C00030 was awarded to TDA Research, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 27, 2021.
How much is contract 75N92021C00030 worth?
The government has obligated $300,000 on 75N92021C00030.
Was contract 75N92021C00030 competed?
The extent of competition for 75N92021C00030 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award